021-51111890
购物车（）
sales@molnova.cn
Tyrphostin AG1433
CAS No. 168835-90-3
Tyrphostin AG1433 ( SU1433; AG1433 )
产品货号. M26493 CAS No. 168835-90-3
Tyrphostin AG1433 is an inhibitor of tyrosine kinases and also a dual inhibitor of PDGFRβ(IC50s = 5.0 μM) and VEGFR-2 (Flk-1/KDR)(IC50s = 9.3 μM).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥599 | 有现货 |
|
| 5MG | ￥988 | 有现货 |
|
| 10MG | ￥1596 | 有现货 |
|
| 25MG | ￥2859 | 有现货 |
|
| 50MG | ￥4358 | 有现货 |
|
| 100MG | ￥6302 | 有现货 |
|
| 500MG | ￥12879 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Tyrphostin AG1433
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Tyrphostin AG1433 is an inhibitor of tyrosine kinases and also a dual inhibitor of PDGFRβ(IC50s = 5.0 μM) and VEGFR-2 (Flk-1/KDR)(IC50s = 9.3 μM).
-
产品描述Tyrphostin AG1433 is an inhibitor of tyrosine kinases and also a dual inhibitor of PDGFRβ(IC50s = 5.0 μM) and VEGFR-2 (Flk-1/KDR)(IC50s = 9.3 μM).(In Vitro):In glioblastoma cells, administration of Tyrphostin AG1433 (0.1-100 μM; 72 hours; GB8B cells) induces moderate cytotoxicity .(In Vivo):Tyrphostin AG1433 is prepared in methylcellulose pellets and applies to the CAMs of 4-6-day-old chicken embryos, and prevents the formation of new vessels under the pellets .
-
同义词SU1433; AG1433
-
通路Angiogenesis
-
靶点VEGFR
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number168835-90-3
-
分子量266.3
-
分子式C16H14N2O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOC1=CC=C(C2=NC3=CC(C)=C(C)C=C3N=C2)C=C1O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Shuyun Shi, et al. A high-speed counter-current chromatography- HPLC-DAD method for preparative isolation and purification of two polymethoxylated flavones from Taraxacum mongolicum. J Chromatogr Sc . May-Jun 2009;47(5):349-53.
产品手册
关联产品
-
SU5204
SU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).
-
Ramucirumab
Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors.
-
BFH-772
A potent, selective and orally active VEGFR2 tyrosine kinase inhibitor with IC50 of 3 nM.
